Induced pluripotent stem cells as a model for diabetes investigation
Adult
Homeodomain Proteins
Male
0301 basic medicine
Induced Pluripotent Stem Cells
Lewis X Antigen
Mice, Obese
Nuclear Proteins
Cell Differentiation
Nanog Homeobox Protein
Middle Aged
Article
3. Good health
Mice, Inbred C57BL
03 medical and health sciences
Diabetes Mellitus, Type 2
Animals
Humans
Female
Octamer Transcription Factor-3
Biomarkers
Cells, Cultured
Embryoid Bodies
Endothelial Progenitor Cells
DOI:
10.1038/srep08597
Publication Date:
2015-02-26T10:14:13Z
AUTHORS (10)
ABSTRACT
AbstractMouse and human induced pluripotent stem cells (iPSCs) may represent a novel approach for modeling diabetes. Taking this into consideration, the aim of this study was to generate and evaluate differentiation potential of iPSCs from lepdb/db (db/db) mice, the model of diabetes type 2 as well as from patients with Maturity Onset Diabetes of the Young 3 (HNF1A MODY). Murine iPSC colonies from both wild type and db/db mice were positive for markers of pluripotency: Oct3/4A, Nanog, SSEA1, CDy1 and alkaline phosphatase and differentiated in vitro and in vivo into cells originating from three germ layers. However, our results suggest impaired differentiation of db/db cells into endothelial progenitor-like cells expressing CD34 and Tie2 markers and their reduced angiogenic potential. Human control and HNF1A MODY reprogrammed cells also expressed pluripotency markers: OCT3/4A, SSEA4, TRA-1–60, TRA-1-81, formed embryoid bodies (EBs) and differentiated into cells of three germ layers. Additionally, insulin expressing cells were obtained from those partially reprogrammed cells with direct as well as EB-mediated differentiation method. Our findings indicate that disease-specific iPSCs may help to better understand the mechanisms responsible for defective insulin production or vascular dysfunction upon differentiation toward cell types affected by diabetes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....